The activation of dendritic cells (DCs) has profound implications and governs the control of adaptive immunity. However, long-term activation might drive exhaustion of immune cells and negatively affect functionality. Here, long-term vs. short-term exposure to bacterial lipopolysaccharide and interferon (IFN)γ was evaluated on human monocyte-derived DCs. Long-term activated DC1s began to undergo apoptosis concomitant with a profound TAM-receptor and efferocytosis-dependent induction of interleukin (IL)-10. Whereas, levels of IL-12p70 and IL-10 were positively correlated upon short-term activation, an inverse association occured upon long-term activation and, while short-term activated CD1a+ DCs were main producers of IL-12p70, CD1a− DCs were the main fraction that underwent apoptosis and released IL-10 upon long-term activation. Moreover, pre-apoptotic long-term activated DCs were no longer able to activate alloreactive IFNγ-responsive T cells present in peripheral blood mononuclear cells from healthy volunteers. The IFNγ response was mediated by IL-12p70, as a strong reduction in IFNγ was observed following blockade with an IL-12p70 neutralizing antibody. Finally, multiplex analysis of DC supernatants revealed a particular pattern of proteins associated with apoptosis, cancer and chronic inflammation partly overlapping with gold standard DCs well-known for their inability to secrete IL-12p70. In conclusion, long-term activated DC1s significantly changed their profile toward a non-functional, tumor-promoting and anti-inflammatory phenotype.
Structured Background: Individuals with common variable immunodeficiency (CVID) are at increased risk of respiratory infections such as SARS-CoV-2 infection due to poorly understood defects within the memory B cell (MBC) compartment. The COVID-19 pandemic presented a unique opportunity to investigate the effects of a novel pathogen and vaccination on the immune system of patients with CVID. Methods: A cross-sectional, single-center, cohort study was used to evaluate the immunologic effect of SARS-CoV-2 vaccination and/or disease on the immune system. We examined the antibody levels, neutralization capacity, MBC, and CD4 + T follicular helper cell (T FH ) response against two SARS-CoV-2 variants in 23 CVID patients and 51 age- and sex-matched healthy individuals with both vaccine-induced and hybrid immunity across multiple immunization events. Results: Our study shows that while CVID patients mount a sufficient CD4 + T FH response against both ancestral and Omicron variants, and some levels of neutralizing antibodies, Spike-specific MBC formation is severely inhibited. Only CVID patients with hybrid immunity were able to generate switched MBCs against both variants. These MBCs were transient however, as Spike-specific switched MBCs did not persist over time in CVID patients. We found that the level of switched MBCs correlated with both CD21 and BAFF-R expression in patients, many of whom expressed low levels of either receptor. Conclusion: Taken together, our study shows that CVID patients generate a sufficient CD4 + T FH response against SARS-CoV-2 but rarely cross-reactive MBCs, and suggest that this effect is correlated with CD21 and BAFF-R dysregulation which might cause switched MBC obsolescence. Trial registration: 21/54057. Funding: Lundbeck Foundation, Novo Nordisk Foundation and Odense University Hospital.